The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours

Peter F M Choong, Toshiyuki Kunisada, John Slavin, Stephen Schlicht, Rodney Hicks

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Introduction: Heterogeneity of cartilage tumours may confound accurate diagnosis and grading resulting in under and over treatment. Improved preoperative assessment of malignancy and grade would be invaluable for developing a rational plan for treatment. We examined correlations between nuclear tracer avidity and malignancy grade in cartilage tumours. Methods: Between 1996 and 2000, 92 consecutive patients with cartilaginous tumours (50 benign, 42 non-metastatic malignant) underwent nuclear scanning. Thallium-201 (TL-201) and pentavalent dimercaptosuccinic acid (DMSAV) were used as nuclear isotopes. Scanning with these agents was performed on separate days 48 hours apart. Static and SPECT images were obtained at 30 m and 4 h after injection of nuclear tracer. Pathology review was undertaken blinded to the results of the nuclear scans and correlations between histologic results and trace uptake at 4 hours examined. Results: 25 patients with negative DMSAV had benign tumours. 15/17 tumours with positive TL-201 had malignant tumours. 11/13 patients with both positive DMSAV and TL-201 scans had intermediate or high grade tumours and 4 of these developed metastases. We have developed an algorithm for the management of patients with tumours that aims to avoid over treatment of low grade tumours and under treatment of high grade tumours. Conclusion: Functional nuclear scanning with TL-201 and DMSAV complements other imaging modalities in the management of cartilaginous tumours.

Original languageEnglish
JournalInternational Seminars in Surgical Oncology
Volume1
DOIs
Publication statusPublished - Nov 8 2004
Externally publishedYes

Fingerprint

Succimer
Neoplasm Staging
Thallium
Neoplasms
Cartilage
Therapeutics
Single-Photon Emission-Computed Tomography
Isotopes

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours. / Choong, Peter F M; Kunisada, Toshiyuki; Slavin, John; Schlicht, Stephen; Hicks, Rodney.

In: International Seminars in Surgical Oncology, Vol. 1, 08.11.2004.

Research output: Contribution to journalArticle

@article{56bb27f80a7f43e4b7d854e363901d14,
title = "The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours",
abstract = "Introduction: Heterogeneity of cartilage tumours may confound accurate diagnosis and grading resulting in under and over treatment. Improved preoperative assessment of malignancy and grade would be invaluable for developing a rational plan for treatment. We examined correlations between nuclear tracer avidity and malignancy grade in cartilage tumours. Methods: Between 1996 and 2000, 92 consecutive patients with cartilaginous tumours (50 benign, 42 non-metastatic malignant) underwent nuclear scanning. Thallium-201 (TL-201) and pentavalent dimercaptosuccinic acid (DMSAV) were used as nuclear isotopes. Scanning with these agents was performed on separate days 48 hours apart. Static and SPECT images were obtained at 30 m and 4 h after injection of nuclear tracer. Pathology review was undertaken blinded to the results of the nuclear scans and correlations between histologic results and trace uptake at 4 hours examined. Results: 25 patients with negative DMSAV had benign tumours. 15/17 tumours with positive TL-201 had malignant tumours. 11/13 patients with both positive DMSAV and TL-201 scans had intermediate or high grade tumours and 4 of these developed metastases. We have developed an algorithm for the management of patients with tumours that aims to avoid over treatment of low grade tumours and under treatment of high grade tumours. Conclusion: Functional nuclear scanning with TL-201 and DMSAV complements other imaging modalities in the management of cartilaginous tumours.",
author = "Choong, {Peter F M} and Toshiyuki Kunisada and John Slavin and Stephen Schlicht and Rodney Hicks",
year = "2004",
month = "11",
day = "8",
doi = "10.1186/1477-7800-1-10",
language = "English",
volume = "1",
journal = "International Seminars in Surgical Oncology",
issn = "1477-7800",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours

AU - Choong, Peter F M

AU - Kunisada, Toshiyuki

AU - Slavin, John

AU - Schlicht, Stephen

AU - Hicks, Rodney

PY - 2004/11/8

Y1 - 2004/11/8

N2 - Introduction: Heterogeneity of cartilage tumours may confound accurate diagnosis and grading resulting in under and over treatment. Improved preoperative assessment of malignancy and grade would be invaluable for developing a rational plan for treatment. We examined correlations between nuclear tracer avidity and malignancy grade in cartilage tumours. Methods: Between 1996 and 2000, 92 consecutive patients with cartilaginous tumours (50 benign, 42 non-metastatic malignant) underwent nuclear scanning. Thallium-201 (TL-201) and pentavalent dimercaptosuccinic acid (DMSAV) were used as nuclear isotopes. Scanning with these agents was performed on separate days 48 hours apart. Static and SPECT images were obtained at 30 m and 4 h after injection of nuclear tracer. Pathology review was undertaken blinded to the results of the nuclear scans and correlations between histologic results and trace uptake at 4 hours examined. Results: 25 patients with negative DMSAV had benign tumours. 15/17 tumours with positive TL-201 had malignant tumours. 11/13 patients with both positive DMSAV and TL-201 scans had intermediate or high grade tumours and 4 of these developed metastases. We have developed an algorithm for the management of patients with tumours that aims to avoid over treatment of low grade tumours and under treatment of high grade tumours. Conclusion: Functional nuclear scanning with TL-201 and DMSAV complements other imaging modalities in the management of cartilaginous tumours.

AB - Introduction: Heterogeneity of cartilage tumours may confound accurate diagnosis and grading resulting in under and over treatment. Improved preoperative assessment of malignancy and grade would be invaluable for developing a rational plan for treatment. We examined correlations between nuclear tracer avidity and malignancy grade in cartilage tumours. Methods: Between 1996 and 2000, 92 consecutive patients with cartilaginous tumours (50 benign, 42 non-metastatic malignant) underwent nuclear scanning. Thallium-201 (TL-201) and pentavalent dimercaptosuccinic acid (DMSAV) were used as nuclear isotopes. Scanning with these agents was performed on separate days 48 hours apart. Static and SPECT images were obtained at 30 m and 4 h after injection of nuclear tracer. Pathology review was undertaken blinded to the results of the nuclear scans and correlations between histologic results and trace uptake at 4 hours examined. Results: 25 patients with negative DMSAV had benign tumours. 15/17 tumours with positive TL-201 had malignant tumours. 11/13 patients with both positive DMSAV and TL-201 scans had intermediate or high grade tumours and 4 of these developed metastases. We have developed an algorithm for the management of patients with tumours that aims to avoid over treatment of low grade tumours and under treatment of high grade tumours. Conclusion: Functional nuclear scanning with TL-201 and DMSAV complements other imaging modalities in the management of cartilaginous tumours.

UR - http://www.scopus.com/inward/record.url?scp=18144427158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144427158&partnerID=8YFLogxK

U2 - 10.1186/1477-7800-1-10

DO - 10.1186/1477-7800-1-10

M3 - Article

VL - 1

JO - International Seminars in Surgical Oncology

JF - International Seminars in Surgical Oncology

SN - 1477-7800

ER -